Screener
Gyre Therapeutics, Inc. GYRE Gyre — Total Assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Deferred tax assets | 9,284 | 6,873 |
| Long-term certificates of deposit | 28,444 | 23,516 |
| Other assets, noncurrent | 7,344 | 7,624 |
| Total assets | $199,255 | $219,763 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $1,236 | $1,335 |
| Due to related parties | 5,085 | 227 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Gyre Therapeutics, Inc.'s gyre — total assets?
- Gyre Therapeutics, Inc. (GYRE) reported gyre — total assets of $59.66M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s gyre — total assets changed year-over-year?
- Gyre Therapeutics, Inc.'s gyre — total assets increased by 91.6% year-over-year, from $31.14M to $59.66M.
- What does gyre — total assets mean?
- This metric represents the total economic resources controlled by the business segment that are expected to provide future benefits. It includes tangible and intangible assets specifically utilized or held by the segment to support its operational objectives. Tracking this provides insight into the scale and capital intensity of the segment's business model.
Ask your AI about Gyre Therapeutics, Inc.'s gyre — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude